Myelodysplastic Syndromes
📧 Sign up to get email alerts when something new happens for Myelodysplastic Syndromes.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia [Phase 2]
Phase 2 clinical trial evaluating umbilical cord blood and placental blood transplantation for hematologic cancers or aplastic anemia. The s…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Combination of 5-azacitidine and Lenalidomide in Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) Myelodysplastic Syndromes [Phase 1]
A Phase 1 trial evaluating the combination of 5-azacitidine and lenalidomide in myelodysplastic syndromes and acute myeloid leukemia was ter…
-
CLINICAL_TRIALS trial_result · 2013-12-17Clinical Trial Update: Study of CC-5013 to Evaluate Safety, Pharmacokinetics and Effectiveness for Japanese Patients With Symptomatic Anemia Associated With Myelodysplastic Syndrome With a Del(5)(q31-33) Abnormality. [Phase 2]
Phase 2 trial evaluating CC-5013 (lenalidomide) in Japanese patients with symptomatic anemia due to myelodysplastic syndrome with del(5)(q31…
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation [Phase 2]
Phase 2 trial evaluating sirolimus, tacrolimus, thymoglobulin, and rituximab as graft-versus-host-disease prophylaxis in haploidentical and …
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: A Phase I Study of WT1 Peptides to Induce Anti-Leukemia Immune Responses Following Transplantation [Phase 1]
A Phase I study evaluating WT1 peptide immunotherapy to induce anti-leukemia immune responses after transplantation was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-12-06Clinical Trial Update: Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes [Phase 3]
Phase 3 trial comparing erythropoietin with or without filgrastim to supportive therapy alone in myelodysplastic syndromes; results posted i…
-
CLINICAL_TRIALS trial_result · 2013-12-05Clinical Trial Update: MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia [Phase 1]
Phase 1 clinical trial update showing results for MLN4924 (pevonedistat) in acute myeloid leukemia, acute lymphoblastic leukemia, and myelod…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome [Phase 2]
An update on a Phase 2 clinical trial of combination chemotherapy for patients with myelodysplastic syndromes, sponsored by ALZA.
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia [Phase 3]
A Phase 3 trial comparing combination chemotherapy with or without bone marrow transplantation in children with acute myeloid leukemia. The …
-
CLINICAL_TRIALS trial_result · 2013-11-26Clinical Trial Update: Azacitidine and Lintuzumab in Treating Patients With Previously Untreated Myelodysplastic Syndromes [Phase 2]
Phase 2 trial evaluating azacitidine with lintuzumab in previously untreated myelodysplastic syndromes was terminated after results were pos…
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Phase 2 Study of Telintra® in Deletion 5q Myelodysplastic Syndrome [Phase 2]
Phase 2 study of Telintra (TLK199) in patients with deletion 5q myelodysplastic syndrome has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Myeloablative Allogeneic Stem Cell Transplantation Using a Naive T-Cell Depleted Peripheral Blood Stem Cell Graft [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating myeloablative allogeneic stem cell transplantation with a naive T-cell depleted peripheral blood graft…
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Phase I/II Trial of Sodium Stibogluconate in Myelodysplastic Syndrome [Phase 1]
A Phase I/II trial of sodium stibogluconate for myelodysplastic syndromes was terminated.
-
CLINICAL_TRIALS trial_result · 2013-11-07Clinical Trial Update: SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes. [Phase 2]
A Phase 2 open-label study of SCIO-469 in patients with myelodysplastic syndromes has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or Myeloma [Phase 2]
A Phase 2 clinical trial update describes using arsenic trioxide to treat patients with recurrent or refractory acute leukemia, chronic myel…
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Amifostine in Treating Patients With Advanced Myelodysplastic Syndrome [Phase 2]
Phase 2 clinical trial update evaluating amifostine for advanced myelodysplastic syndromes; current trial status is not provided.
-
CLINICAL_TRIALS trial_result · 2013-10-28Clinical Trial Update: Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia [Phase 3]
Phase 3 trial evaluating low-dose or high-dose conditioning regimens before peripheral blood stem cell transplantation in patients with myel…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes [Phase 1]
A Phase 1 study evaluating the combination of vorinostat with idarubicin in patients with relapsed or refractory leukemia or myelodysplastic…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Tanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes [Phase 1]
Phase 1 trial evaluating Tanespimycin in combination with Cytarabine in adults with relapsed or refractory acute myeloid leukemia, acute lym…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: 7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic Syndromes [Phase 1]
Phase 1 trial of the combination therapy 7-Hydroxystaurosporine and perifosine in adults with relapsed or refractory acute leukemias, chroni…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: A Pharmacokinetic And Pharmacodynamic Study Of Oral Lenalidomide (Revlimid) In Subjects With Low- Or Intermediate-1-Risk Myelodysplastic Syndromes [Phase 1, Phase 2]
A pharmacokinetic and pharmacodynamic study of oral lenalidomide (Revlimid) in patients with low- or intermediate-1-risk myelodysplastic syn…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Decitabine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia [Phase 1]
Phase 1 trial of decitabine in patients with myelodysplastic syndromes or acute myeloid leukemia; the study status is terminated.
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: SJG-136 in Treating Patients With Relapsed or Refractory Acute Leukemia, Myelodysplastic Syndromes, Blastic Phase Chronic Myelogenous Leukemia, or Chronic Lymphocytic Leukemia [Phase 1]
Phase 1 trial of SJG-136 in relapsed or refractory hematologic cancers (acute myeloid leukemia subtypes, myelodysplastic syndromes, blast-ph…
-
CLINICAL_TRIALS trial_result · 2013-09-27Clinical Trial Update: Lenalidomide Maintenance Therapy in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) [Phase 2]
A Phase 2 trial evaluating lenalidomide maintenance therapy in patients with myelodysplastic syndromes or acute myeloid leukemia was termina…
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia [Phase 3]
This entry reports a Phase 3 clinical trial evaluating combination chemotherapy in older patients with acute myeloid leukemia; the current s…